Suppr超能文献

托拉塞米是用于动脉高血压长期治疗的有效袢利尿剂。

[Torasemide is the effective loop diuretic for long-term therapy of arterial hypertension].

作者信息

Preobrazhenskiĭ D V, Nekrasova N I, Khoseva E N, Arystanova A, Talyzina I V, Pataraia S A

出版信息

Kardiologiia. 2011;51(4):67-73.

Abstract

Torasemide is a loop diuretic and has been used for the treatment of both acute and chronic congestive heart failure (CHF) and arterial hypertension (AH). Torasemide is similar to other loop diuretics in terms of its mechanism of diuretic action. It has higher bioavailability (>80%) and a longer elimination half-life (3 to 4 hours) than furosemide. In the treatment of CHF torasemide (5 to 20 mg/day) has been shown to be an effective diuretic. Non-diuretic dosages (2.5 to 5 mg/day) of torasemide have been used to treat essential AH, both as monotherapy and in combination with other antihypertensive agents. When used in these dosages, torasemide lowers diastolic blood pressure to below 90mm Hg in 70 to 80% of patients. Antihypertensive efficacy of torasemide is similar to that of thiazides and related compounds. Thus low-dose torasemide constitutes an alternative to thiazides in the treatment of essential AH.

摘要

托拉塞米是一种袢利尿剂,已用于治疗急慢性充血性心力衰竭(CHF)和动脉高血压(AH)。托拉塞米在利尿作用机制方面与其他袢利尿剂相似。它的生物利用度较高(>80%),消除半衰期(3至4小时)比呋塞米长。在CHF治疗中,托拉塞米(5至20毫克/天)已被证明是一种有效的利尿剂。托拉塞米的非利尿剂量(2.5至5毫克/天)已用于治疗原发性AH,既作为单一疗法,也与其他抗高血压药物联合使用。当以这些剂量使用时,托拉塞米可使70%至80%的患者舒张压降至90毫米汞柱以下。托拉塞米的抗高血压疗效与噻嗪类及相关化合物相似。因此,低剂量托拉塞米在原发性AH治疗中可作为噻嗪类药物的替代药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验